Revolutionize your practice with personalized reproductive forecasting
Standard Inputs, Instant Insights
Simple Data Collection
- Basic demographics
- Health information
- Antral Follicle Count (AFC)
Immediate Results
No blood draws, no waiting for results. Perform and interpret within a single consult.
- Distinguish your practice by delivering uniquely personalized care.
- Guide fertility planning decisions with unprecedented foresight.
- Proactively time menopause-relatedhealth recommendations.
- Minimize reactive, symptom-driven care.
Frequently Asked Questions
Our tool is not a diagnostic device. It is intended to provide low-risk, informational support to clinicians and patients to help guide conversations around life planning. The FDA has issued guidance stating that it does not intend to enforce regulatory requirements for such low-risk software tools that are used to support clinical decision-making without being relied upon as the sole basis for treatment or diagnosis. We will be actively identifying further necessaryregulatory engagement as our product evolves to ensure clinical confidence and federal compliance.
Not yet; currently it is out-of-pocket, with an application to qualify for insurance reimbursement anticipated in the future.
Our model is validated as superior to population-wide data and retrospective public health data, with ongoing clinical studies to enhance precision in individual forecasting. See our papers here.
We hope to soon add capabilities for repeated measures which will further refine each individual's forecast. Additional variables for further personalization are also in the works.
Our tool utilizes follicle threshold estimates that have demonstrated equivalence to the STRAW criteria developed by the NIH. Under these criteria, perimenopause is a persistent 7 day change in consecutive cycle length, while menopause onset is retrospectively defined after twelve months without a menstrual period.